(Q41047731)

26 September 2017

1 reference

title

Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci (English)

1 reference

26 September 2017

main subject

gram-positive bacteria

0 references

author name string

M G Cormican

series ordinal

1

1 reference

26 September 2017

R N Jones

series ordinal

2

1 reference

26 September 2017

language of work or name

1 reference

1 January 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

51 Suppl 1

1 reference

26 September 2017

page(s)

6-12

1 reference

Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital

26 September 2017

cites work

1 reference

12 December 2020

Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital.

1 reference

12 December 2020

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

1 reference

12 December 2020

Major trends in the microbial etiology of nosocomial infection.

1 reference

12 December 2020

Hospital-acquired infections: diseases with increasingly limited therapies

1 reference

12 December 2020

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

1 reference

12 December 2020

In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci

1 reference

12 December 2020

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents

1 reference

12 December 2020

The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.

1 reference

12 December 2020

In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods

1 reference

12 December 2020

Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species

1 reference

12 December 2020

Emergence of Enterococcus as a Significant Pathogen

1 reference

12 December 2020

Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus

1 reference

12 December 2020

Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds

1 reference

12 December 2020

Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in Taiwan.

1 reference

12 December 2020

Current perspectives on glycopeptide resistance.

1 reference

12 December 2020

Comparative in-vitro activity of RP 59500

1 reference

12 December 2020

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

1 reference

12 December 2020

Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species

1 reference

12 December 2020

Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital

1 reference

12 December 2020

In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures

1 reference

12 December 2020

In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and Enterococci

1 reference

12 December 2020

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

12 December 2020

In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria

1 reference

12 December 2020

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

1 reference

12 December 2020

Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates.

1 reference

12 December 2020

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

12 December 2020

Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers

1 reference

12 December 2020

The life and times of the Enterococcus

1 reference

12 December 2020

Antimicrobial susceptibility of coagulase-negative staphylococci

1 reference

12 December 2020

van A-Mediated vancomycin-resistant Enterococcus spp. in sewage

1 reference

12 December 2020

Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group

1 reference

12 December 2020

Update on clinical significance of coagulase-negative staphylococci

1 reference

12 December 2020

In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.

1 reference

12 December 2020

Identifiers

1 reference